Skip to main content Site Map
  1. Home >
  2. For health professionals >
  3. Programmes & research >
  4. Research at National Women's

Research at National Women's

On this page: 

Research Governance Group (RGG)

Scope

The RGG have oversight of all research proposals within Women’s Health and Newborn Services, with the exception of compliance audits

 Purpose of the Research Governance Group (RGG)

  • To support a culture of research excellence in all aspects of women’s and newborn health, at Women’s Health and Newborn Services, Starship Children’s Hospital,
  • To enable research at Women’s Health and Newborn
  • To promote integration of research into the clinical
  • To provide a safe research environment for staff and
  • To coordinate research to avoid duplication and burden on staff and patients and
  • To reflect the values of the group

All Research Projects within women’s and newborn health will be reviewed by the RGG and ALSO by the Te Toka Tumai RRC.

 To find out more about our research, visit the Research page on the Te Toka Tumai Auckland Hospital website().

Research governance meetings

Please refer to the staff intranet for current research governance meeting dates.

Documentation to be considered at a meeting needs to be received one week prior to the meeting date.

BEAD Feasibility study

Does the baby head elevation balloon (Fetal Pillow®) make an emergency caesarean section, when the cervix is fully dilated, safer for māmā and pēpi?

A 12 month feasibility study is starting from the 7th August 2023 at Auckland Hospital. This trial may be suitable for hapu māmā who are term with a cephalic, singleton pregnancy needing a caesarean at 10cm dilated.

For more information visit the BEAD Feasibility Study website() or contact the research team at thebeadstudy@auckland.ac.nz

C*Steroid Study

Can we safely reduce the risk of breathing problems for newborn babies by giving corticosteroid injections to their mothers before a planned caesarean section?

This trial is underway at Auckland Hospital and Liggins Institute, The University of Auckland. This trial may be suitable for you if you are having a planned caesarean section at 35 – 39+6 weeks of pregnancy. Find our more at the C*STEROID Trial website www.liggins.auckland.ac.nz/csteroid() or contact the team at csteroid@auckland.ac.nz

FIIX study

The FIIX Study is a clinical trial comparing the two main fertility procedures available through public funding in New Zealand – The Fertility and In Vitro Fertilisation (IVF) and Intra Uterine Insemination (IUI) trial in couples with uneXplained infertility.Couples with unexplained infertility who have been accepted for publicly funded fertility treatment are suitable to participate.For more information, visit the FIIX study website().

Genetic testing of Embryos

Researchers want your opinion on access to preimplantation testing of embryos in Aotearoa. See the Fertility Plus Research page() for more information.

Maternal Psoriasis and Infant Neurodevelopmental outcomes (MaPINO) Study

Do inflammatory conditions, such as psoriasis, influence a child’s development? We have designed a study to research this question and are inviting pregnant women with and without psoriasis to take part. All women will have dedicated surveillance of their psoriasis (and dermatology review if needed), and all children will get a full neurodevelopmental assessment at two years of age (plus a small gift and parking and travel expenses). Women less than 15 weeks pregnant will also have blood tests to look at markers of inflammation.If you are interested or would like more information, please contact: Ms Susan Law Research Nurse, p. 021 744 958 or email mapino@adhb.govt.nz.Visit the MaPINO study page() for more information about participating.

Mate Whenua Study

The Matua Whenua study is a clinical trial comparing two methods of follow up after early medical abortion (EMA): two blood tests, or a self-assessment that includes a urine pregnancy test. It is important to follow up after taking the abortion medications to ensure that you are no longer pregnant. The aim of this project is to find out which method is safer, and which is more acceptable to women. Anyone having an EMA at Epsom Day Unit is eligible to participate. For more information visit the Mate Whenua website() or email matewhenua@auckland.ac.nz.

Preimplantation genetic testing

Researchers want your opinion on access to preimplantation testing of embryos in Aotearoa. Clinicians, scientists, Māori, Pasifika, and people with a heritable disorder are all encouraged to take part.

Click here for a participation information sheet. [PDF, 279 KB]

Link to survey.()